Semaglutide (also injected weekly) reduced body weight by around 11% after 24 to 68 weeks, with effects likely sustained up to two years, drawing on 18 randomized controlled trials (27 949 participants)
The objective of the study is to demonstrate superiority to placebo in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score reduction and in body weight reduction from baseline to week 68 in people with a BMI 27.0 kg/m and who met clinical and radiological American College of Rheumatology Criteria for knee osteoarthritis
A large study of more than 3,500 pregnancies found that first-trimester exposure to #GLP-1 receptor agonists was not associated with a substantial increase in pregnancy loss, major congenital anomalies, or abnormal fetal growth
Batch-level standards and documentation help confirm that the material is appropriate for its stated research purpose
Made in GMP-certified facilities under U.S
This is why ongoing medical supervision and individualized treatment planning are essential
